CompletedNot Applicable

ERAS in Colorectal Surgery Diminishes the Negative Impact of Sarcopenia on Short Term Outcomes

Poland171 participantsStarted 2014-01

Plain-language summary

So far, the impact of sarcopenia has been analysed only in patients undergoing traditional surgical procedures (laparotomy) or those with metastatic spread. As the ERAS protocol combined with minimally invasive access decreases postoperative metabolic disorders, it seems possible that it can limit the deleterious impact of sarcopenia as well. The aim of this study was to investigate whether the use of ERAS protocol in colorectal cancer patients influences the postoperative risk due to sarcopenia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * confirmed adenocarcinoma of colon or rectum * complete preoperative radiology assessment with abdominal CT scan * laparoscopic resection * perioperative care according to ERAS principles Exclusion Criteria: * unavailability of a preoperative abdominal CT scan (within 30 days prior surgery) * emergency or initially open surgery * patients treated with endoscopic techniques: transanal endoscopic microsurgery (TEM), transanal total mesorectal excision (TaTME) * concomitant inflammatory bowel diseases.

What they're measuring

Complications

Timeframe: up to 30 days post surgery

Trial details

NCT IDNCT02618811

SponsorJagiellonian University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-10

View on ClinicalTrials.gov More Sarcopenia trials